This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kasahara, M. Articles by Ishikawa, K. Search for Related Content PubMed PubMed Citation Articles by Kasahara, M. Articles by Ishikawa, K.

Thymidylate Synthase Expression Correlates Closely with E2F1 Expression in Colon Cancer¹

The 3rd Department of Surgery [M. K., T. E., Y. I., M. F.] and Department of Pharmacology [Y. T., T. N., S. A., K. I.], Nihon University School of Medicine, Tokyo 173-8610, Japan

Thymidylate synthase (TS) is thought to be one of the target genes that the E2F1 transcription factor binds to and regulates. However, the relationship between the expressions of TS and E2F1 in primary colon cancer specimens remains unclear. The aim of this study was to define the relation of TS and E2F1 gene expressions in tumor samples from 23 colon cancer patients. TS and E2F1 gene expressions were measured by TaqMan reverse transcription-PCR assay using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal standard and expressed as a TS:GAPDH or E2F1:GAPDH mRNA ratio. A close relationship was found between TS gene expression and E2F1 gene expression (r² = 0.598, P < 0.001) in 23 tumor samples analyzed. Surprisingly, a high correlation between TS gene expression and E2F1 gene expression was observed even in advanced tumors from stage IV colon cancer patients. These results suggest that transcription of the TS gene may be regulated by E2F1 in primary colon cancer specimens and that this gene-regulatory pathway from E2F1 to TS may be highly conserved during malignant progression. Four of the 23 patients showed TS overexpression with increased E2F1 expression. These results suggest that the ability of a tumor to increase TS expression may possibly be due to an overexpression of E2F1. Although the number of patients was relatively small, our study provides new insights into the molecular mechanisms underlying the regulation of TS expression in colon cancers.

This article has been cited by other articles:

				T. E. McManus, A-M. Marley, N. Baxter, S. N. Christie, J. S. Elborn, H. J. O'Neill, P. V. Coyle, and J. C. Kidney High levels of Epstein-Barr virus in COPD Eur. Respir. J., June 1, 2008; 31(6): 1221 - 1226. [Abstract] [Full Text] [PDF]

				J. Lee, C. K. Park, J. O. Park, T. Lim, Y. S. Park, H. Y. Lim, I. Lee, T. S. Sohn, J. H. Noh, J. S. Heo, et al. Impact of E2F-1 Expression on Clinical Outcome of Gastric Adenocarcinoma Patients with Adjuvant Chemoradiation Therapy Clin. Cancer Res., January 1, 2008; 14(1): 82 - 88. [Abstract] [Full Text] [PDF]

				C.-l. Huang, D. Liu, J. Nakano, H. Yokomise, M. Ueno, K. Kadota, and H. Wada E2F1 Overexpression Correlates with Thymidylate Synthase and Survivin Gene Expressions and Tumor Proliferation in Non Small-Cell Lung Cancer Clin. Cancer Res., December 1, 2007; 13(23): 6938 - 6946. [Abstract] [Full Text] [PDF]

				R. Sowers, J. Toguchida, J. Qin, P. A. Meyers, J. H. Healey, A. Huvos, D. Banerjee, J. R. Bertino, and R. Gorlick mRNA Expression Levels of E2F Transcription Factors Correlate with Dihydrofolate Reductase, Reduced Folate Carrier, and Thymidylate Synthase mRNA Expression in Osteosarcoma Mol. Cancer Ther., June 1, 2003; 2(6): 535 - 541. [Abstract] [Full Text] [PDF]

				A. S. Weinmann, P. S. Yan, M. J. Oberley, T. H.-M. Huang, and P. J. Farnham Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis Genes & Dev., January 15, 2002; 16(2): 235 - 244. [Abstract] [Full Text] [PDF]